All products / DC12281
Olutasidenib (FT-2102)
Pack sizes and prices
| Pack size | Price |
|---|---|
| 100 mg | $950 USDRequest a quote → |
| 250 mg | $1,500 USDRequest a quote → |
| 1 g | $2,900 USDRequest a quote → |
In stock. Contact our team for lead time, shipping and final quotation.
Product overview
Olutasidenib (FT-2102) is a highly potent, selective small molecule inhibitor of IDH1 mutations. Scientists use it in the research of human acute myeloid leukemia. To our delight, it has entered clinical research. In the phase 1/2 study, Olutasidenib is well tolerated both as a sing-treatment and in combination with azacitidine.Overall, Olutasidenib exhibits favorable safety and PK/PD. It inhibits IDH1 mutations in AML patients. Further study need to be done to explore more potential in the treatment of acute myeloid leukemia.
For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.
Identity and specifications
| Catalog number | DC12281 |
|---|---|
| Product name | Olutasidenib (FT-2102) |
| CAS | 1887014-12-1 |
| Molecular formula | C18H15ClN4O2 |
| Molecular weight | 354.79 |
| Purity | >98% |
| SMILES | N#CC1=CC=C(N[C@H](C2=CC3=C(NC2=O)C=CC(Cl)=C3)C)C(N1C)=O |
Source-listed specifications; the batch COA applies.
Source and product documents
The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.
DC Chemicals — Olutasidenib (FT-2102) (DC12281)